Surrogate endpoint validation: Statistical elegance versus clinical relevance

Statistical Methods in Medical Research

Volumn 17, Issue 5, 2008, Pages 477-486

  Green, E M ^a   Yothers, G ^b   Sargent, Daniel J ^a  

^a MAYO CLINIC   (United States)

^b NSABP Foundation Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; BIVARIATE ANALYSIS; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONFERENCE PAPER; DISEASE FREE SURVIVAL; EARLY CANCER; HUMAN; LINEAR REGRESSION ANALYSIS; OUTCOMES RESEARCH; OVERALL SURVIVAL; PROPORTIONAL HAZARDS MODEL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; VALIDATION STUDY;

BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; COLORECTAL NEOPLASMS; HUMANS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 52649149158     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1177/0962280207081863     Document Type: Conference Paper

References (8)

1. Begg CB, Leung DHY. On the use of surrogate end points in randomized trials. Journal of the Royal Statistical Society (Series A) 2000; 163: 15-24.
2. Prentice RL Surrogate endpoints in clinical trials: Definition and operational criteria. Statistics in Medicine 1989; 8: 431-40.
3. Freedman LS, Graubard BI, Schatzkin A. Statistical validation of intermediate endpoints for chronic diseases. Statistics in Medicine 1992; 11: 167-78.
4. Burzykowski T., Molenberghs G., Buyse M., Geys H., Renard D. Validation of surrogate end points in multiple randomized clinical trials with failure time end points. Applied Statistics 2001; 50: 405-22.
5. Buyse M., Molenberghs G., Burzykowski T., Renard D., Geys H. The validation of surrogate endpoints in meta-analyses of randomized experiments. Biostatistics 2000; 1: 49-67.
6. Sargent DJ, Wieand HS, Haller DG, Gray R., Buyse M., Labianca R. et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: Individual patient data from 20,898 patients on 18 randomized trials. Journal of Clinical Oncology 2005; 23: 8664-70.
7. Cox DR Regression models and life tables. Journal of the Royal Statistical Society (Series B) 1972; 34:187-220.
8. Baker SG, Kramer BS A perfect correlate does not a surrogate make. BMC Medical Research Methodology 2003; 3:16.